FDA-approved artificial intelligence products in abdominal imaging: A comprehensive review

Area of Science:

• Radiology
• Medical Imaging
• Artificial Intelligence

Background:

• Artificial intelligence (AI) is rapidly evolving within the field of radiology.
• The Food and Drug Administration (FDA) has established a clearance process for AI medical devices.
• AI applications are increasingly being developed for diagnostic and non-diagnostic tasks in medical imaging.

Purpose of the Study:

• To provide a comprehensive overview of FDA-approved AI products in abdominal imaging.
• To explore the evolution and impact of AI in radiology.
• To examine the FDA clearance process for AI in abdominal imaging.

Main Methods:

• Literature review to identify and categorize AI products for abdominal imaging.
• Analysis of AI applications in liver, prostate, bladder, and kidney imaging.
• Evaluation of AI functionalities in disease detection, image quality, and workflow optimization.

Main Results:

• Numerous FDA-approved AI products for abdominal imaging have been identified.
• AI applications include lesion detection, characterization, volume estimation, and quantification of organ health.
• AI solutions demonstrate improved diagnostic accuracy, streamlined workflows, and optimized patient care.

Conclusions:

• AI integration in abdominal imaging signifies a paradigm shift in radiology.
• FDA-approved AI empowers radiologists with advanced tools for diagnosis and treatment planning.
• Collaboration is key to realizing AI's full potential in abdominal radiology.